Drano vs. MR CLEAN Review of New Endovascular Therapy for Acute Ischemic Stroke Patients
|
|
- Garry Erik Powell
- 5 years ago
- Views:
Transcription
1 Drano vs. MR CLEAN Review of New Endovascular Therapy for Acute Ischemic Stroke Patients Peter Panagos, MD, FACEP, FAHA Associate Professor Emergency Medicine and Neurology Washington University School of Medicine
2 Disclosures Speaker s Bureau: Genentech Research Funding: NIH, St Luke s Hospital (KC) Consultant: AHA/ASA ACLS 2016 (Volunteer) Scientific Advisory Board: Pulse Therapeutics
3 Burden of Cerebrovascular Disease Stroke Death Rates Adults > 34 years of age, by county Data Source: National Vital Statistics System and US Census Bureau
4 The Penumbra Shrinks as Time from Onset of Ischemia Increases Oligemia: > 20 ml/100g/min Penumbra: 8 20 ml/100g/min Core: < 6-8 ml/100g/min
5 Time is Brain Time interval NNT for one Absolute risk good outcome reduction 0-90 min 5 20% Combined data from ECASS I-III, EPITHET, NINDS, ATLANTIS; Lees et al, Lancet 375: , min 9 11% min %
6 Faster Stroke Treatment is Better Treatment Patients treated within 60 mins. experience improved outcomes, including lower in-hospital mortality and reduced long-term disability GC Fonarow et al. JAMA. 2014;311(16): Saver et al. JAMA. 2013;309(23):2480-8
7 Basic Stroke Anatomy 101 Goyal M et al. N Engl J Med 2015;372:
8 IV tpa Doesn t Always Work Angiographic evaluation to identify presence and location of clot and effect of agent in 93 patients IV t-pa ( mg/kg) given 0-6 hours Angiographic Findings 26% (12/46) complete or partial lysis in M1, M2 9% (2 of 23) lysis in ICA Similar data by del Zoppo (Ann Neurol 1992) and Tomsick (AJNR 1996), Bhatia (Stroke 2010) Wolpert S, et al AJNR 1993; 14: 3-13.
9 Longer Clot Length = Less Chance to Work Reidel et al. Stroke 2011
10 Recent results of four trials
11 Now the Science.
12
13 MR-CLEAN Aim: To assess the effect of intra-arterial (IA) treatment on functional outcome after acute ischemic stroke (AIS) caused by a proven intracranial arterial occlusion, against a background of best medical management (with or without IV tpa) Design: multicenter, prospective randomized open, blinded endpoint (PROBE)
14 MR-CLEAN Study population: Netherlands Inclusion criteria: AIS, CTA w/ anterior circulation occlusion, age 18, NIHSS 2 Intervention: open Mechanical treatment, delivery of thrombolytic agent, or both Timeframe: IA treatment within 6 hours
15 MR-CLEAN Primary outcome: modified Rankin score (mrs) at 90 days Several clinical secondary outcomes (not covered here) Several neuro-imaging outcomes (not covered here)
16 MR-CLEAN
17 MR-CLEAN SWIFT-PRIME EXTEND-IA ESCAPE N Baseline NIHSS % with IV tpa Device Usage mrs 90d 500 patients IAT control - 17 IAT - 18 control - 87% IAT - 91% control 97% stent retriever IAT: 32.6% Control: 19.1% NNT for mrs 0-2 at 90 days sich 7 IAT: 7.7% Control: 6.4%
18
19 SWIFT-PRIME Aim: To determine if subjects experiencing an AIS due to large vessel occlusion (LVO), treated with combined IV tpa and Solitaire device within 6 hours of symptom onset, have less stroke-related disability (mrs) than subjects treated with IV tpa alone. Design: multicenter, prospective randomized open, blinded endpoint (PROBE)
20 SWIFT-PRIME Study population: United States and Europe Inclusion criteria: AIS, CTA/MRA w/ occlusion at intracranial ICA / M1 / carotid terminus, age 18-80, NIHSS 8-29, pre-stroke mrs 1 Intervention: Solitaire device (stent retriever) Timeframe: IV treatment within 4.5 hours and IA treatment within 6 hours (within 90 minutes of qualifying imaging)
21 SWIFT-PRIME Primary outcome: modified Rankin score (mrs) at 90 days Several clinical secondary outcomes (not covered here) Several neuro-imaging outcomes (not covered here)
22 SWIFT-PRIME Enrollment ended early due to MR-CLEAN (n=196)
23 MR-CLEAN SWIFT-PRIME EXTEND-IA ESCAPE N Baseline NIHSS % with IV tpa Device Usage mrs 90d 500 patients IAT control - 17 IAT - 18 control - 87% IAT - 91% control 97% stent retriever IAT: 32.6% Control: 19.1% IAT - 98 control - 17 IAT - 17 control - 100% IAT - 100% control Solitaire IAT: 60.2% Control: 35.5% NNT for mrs 0-2 at 90 days 7 4 sich IAT: 7.7% Control: 6.4% IAT: 1.0% Control: 3.1%
24
25 EXTEND-IA Rationale: To select patients with the best chance of benefit from reperfusion ( Dual Target ) with a proven major vessel occlusion and salvageable tissue with ischemic core < 70 ml (CT perfusion), treat as fast as possible, using the most effective device (stent retriever) Design: multicenter, prospective randomized open, blinded endpoint (PROBE)
26 EXTEND-IA Study population: Australia & New Zealand Inclusion criteria: AIS, CTA/MRA w/ occlusion at ICA / M1 / M2 PLUS mismatch with ischemic core < 70mL, age 18, no specified NIHSS, pre-stroke mrs 1 Intervention: Solitaire device (stent retriever) Timeframe: IV treatment within 4.5 hours and IA treatment within 6 hours
27 EXTEND-IA Primary outcomes: 24 hour MRI reperfusion 3 day NIHSS Several clinical secondary outcomes mrs at 90 days Several neuro-imaging outcomes (not covered here)
28 EXTEND-IA Enrollment ended early due to MR-CLEAN (n=70)
29 MR-CLEAN SWIFT-PRIME EXTEND-IA ESCAPE N 500 patients IAT control IAT - 98 control IAT - 35 control Baseline NIHSS - 17 IAT - 18 control - 17 IAT - 17 control - 17 IAT - 13 control % with IV tpa - 87% IAT - 91% control - 100% IAT - 100% control - 100% IAT - 100% control Device Usage 97% stent retriever Solitaire Solitaire mrs 90d IAT: 32.6% Control: 19.1% IAT: 61.1% Control: 35.5% IAT: 71% Control: 40% NNT for mrs 0-2 at 90 days sich IAT: 7.7% Control: 6.4% IAT: 1.0% Control: 3.1% IAT: 0% Control: 6%
30
31 ESCAPE Aim: to answer the question: Do I take this patient to endovascular treatment (thrombectomy)? Design: multicenter, prospective randomized open, blinded endpoint (PROBE)
32 ESCAPE Study population: Canada, US, Korea, UK & Ireland Inclusion criteria: AIS, CTA w/ occlusion at carotid terminus / M1 / 2 or more M2s PLUS moderate to good collaterals, age 18, NIHSS > 5, good functional status prior to stroke Intervention: mechanical thrombolysis (including stent retriever) Timeframe: Last-seen-well time to randomization < 12 hours and IA treatment started within 60 minutes of qualifying imaging
33 Multi-phase CTA Conventional Mid Venous Late Venous Arch to Vertex Phase Phase
34 ESCAPE Primary outcome: modified Rankin score (mrs) at 90 days Several clinical secondary outcomes (not covered here) Several neuro-imaging outcomes (not covered here)
35 ESCAPE Enrollment ended early due to MR-CLEAN (n=315)
36 MR-CLEAN SWIFT-PRIME EXTEND-IA ESCAPE N 500 patients IAT control IAT - 98 control IAT - 35 control IAT control Baseline NIHSS - 17 IAT - 18 control - 17 IAT - 17 control - 17 IAT - 13 control - 16 IAT - 17 control % with IV tpa - 87% IAT - 91% control - 100% IAT - 100% control - 100% IAT - 100% control - 73% IAT - 79% control Device Usage 97% stent retriever Solitaire Solitaire 86% stent retriever mrs 90d IAT: 32.6% Control: 19.1% IAT: 61.1% Control: 35.5% IAT: 71% Control: 40% IAT: 53% Control: 29.3% NNT for mrs 0-2 at 90 days sich IAT: 7.7% Control: 6.4% IAT: 1.0% Control: 3.1% IAT: 0% Control: 6% IAT: 3.6% Control: 2.7%
37 SUMMARY
38 MR-CLEAN SWIFT-PRIME EXTEND-IA ESCAPE Baseline NIHSS - 17 IAT - 18 control - 17 IAT - 17 control - 17 IAT - 13 control - 16 IAT - 17 control % with IV tpa Revasc Rates (TICI 2b/3 ) - 87% IAT - 91% control - 100% IAT - 100% control - 100% IAT - 100% control - 73% IAT - 79% control IAT: 58.7% IAT: 88% IAT: 86% IAT: 72.4% mrs 90d IAT: 32.6% Control: 19.1% IAT: 61.1% Control: 35.5% IAT: 71% Control: 40% IAT: 53% Control: 29.3% NNT mrs 0-2 at 90d sich IAT: 7.7% Control: 6.4% IAT: 1.0% Control: 3.1% IAT: 0% Control: 6% IAT: 3.6% Control: 2.7% Mortality at 90 days IAT: 21% Control: 22% IAT: 12.2% Control: 25.8% IAT: 9% Control: 20% IAT: 10% Control: 19%
39 Summary Slightly different inclusion/exclusion criteria Now Level I A Recommendations AHA Focused Update Statement (March 2015) All focused on minimizing time to intervention Fairly consistent results overall NNT = 3-4 for mrs 0-2 at 90 days NNT = 8 for MRS 0-2 at 90 days for IV tpa How do we implement this new evidence going forward?
40 What Does This Mean For Prehospital Care?
41 2015: All Stroke Care is Note Equal Specialty Care is Limited 91 CSC 1,200 PSC TBD ASRH Stroke Care is Comprehensive Large AIS, ICH, SAH Multi-system disease Surgical or endovascular expertise 24/7, 365 NICU Research, Education Outcomes
42 Why Doesn t EMS Just Triage the Right Patient to the Right (CSC) Hospital?
43 EMS Field Triage in Stroke: Not Exact Science Yet Often inaccurate for stroke type, size, severity Cannot predict deterioration or complications Patient preference Politics (e.g. Regional plans, CMS rules, etc ) Messaging unclear (e.g. Marketing vs. Quality)
44 Next Steps in Stroke Care Regionalization Coordination Selective Triage Track & Report Quality Adapt to Changes in Evidence
45 St Louis EMS Regional Plan Draft-Approved
46 AHA/ASA Mission: Lifeline Stroke Routing Template Draft
47 Thank You!
Stroke, Stroke, Stroke Where Do We Stop on the River? Comprehensive vs. Primary Stroke Centers
Stroke, Stroke, Stroke Where Do We Stop on the River? Comprehensive vs. Primary Stroke Centers Peter D. Panagos, MD, FAHA, FACEP Departments of Neurology and Emergency Medicine Washington University School
More informationBroadening the Stroke Window in Light of the DAWN Trial
Broadening the Stroke Window in Light of the DAWN Trial South Jersey Neurovascular and Stroke Symposium April 26, 2018 Rohan Chitale, MD Assistant Professor of Neurological Surgery Vanderbilt University
More informationUPDATES IN INTRACRANIAL INTERVENTION Jordan Taylor DO Metro Health Neurology 2015
UPDATES IN INTRACRANIAL INTERVENTION Jordan Taylor DO Metro Health Neurology 2015 NEW STUDIES FOR 2015 MR CLEAN ESCAPE EXTEND-IA REVASCAT SWIFT PRIME RECOGNIZED LIMITATIONS IV Alteplase proven benefit
More informationDisclosures. Current Management of Acute Ischemic Stroke. Overview. Focal brain ischemia. Nerissa U. Ko, MD, MAS Professor of Neurology May 8, 2015
Disclosures Current Management of Acute Ischemic Nerissa U. Ko, MD, MAS Professor of Neurology May 8, 2015 Nothing to disclose Research Funding: American Heart Association NIH/NINDS Selected slides courtesy
More informationMechanical Thrombectomy: Where Are We Now? T. Adam Oliver, MD Tallahassee Neurological Clinic Tallahassee, Florida TMH Neurosymposium June 11, 2016
Mechanical Thrombectomy: Where Are We Now? T. Adam Oliver, MD Tallahassee Neurological Clinic Tallahassee, Florida TMH Neurosymposium June 11, 2016 none DISCLOSURES Where did we come from? Spiotta, et
More informationMechanical thrombectomy in Plymouth. Will Adams. Will Adams
Mechanical thrombectomy in Plymouth Will Adams Will Adams History Intra-arterial intervention 1995 (NINDS) iv tpa improved clinical outcome in patients treated within 3 hours of ictus but limited recanalisation
More informationStroke Update Elaine J. Skalabrin MD Medical Director and Neurohospitalist Sacred Heart Medical Center Stroke Center
Stroke Update 2015 Elaine J. Skalabrin MD Medical Director and Neurohospitalist Sacred Heart Medical Center Stroke Center Objectives 1. Review successes in systems of care approach to acute ischemic stroke
More informationStroke Clinical Trials Update Transitioning to an Anatomic Diagnosis in Ischemic Stroke
Stroke Clinical Trials Update Transitioning to an Anatomic Diagnosis in Ischemic Stroke Alexander A. Khalessi MD MS Director of Endovascular Neurosurgery Surgical Director of NeuroCritical Care University
More informationEndovascular Stroke Therapy
Endovascular Stroke Therapy Update with Emphasis on Practical Clinical and Imaging Considerations Sachin Kishore Pandey, MD, FRCPC Disclosures I have no relevant financial disclosures or conflict of interest
More informationHow to Interpret CT/CTA for Acute Stroke in the Age of Endovascular Clot Retrieval
How to Interpret CT/CTA for Acute Stroke in the Age of Endovascular Clot Retrieval Peter Howard MD FRCPC Disclosures No conflicts to disclose How to Interpret CT/CTA for Acute Stroke in the Age of Endovascular
More informationEndovascular Treatment for Acute Ischemic Stroke
ular Treatment for Acute Ischemic Stroke Vishal B. Jani MD Assistant Professor Interventional Neurology, Division of Department of Neurology. Creighton University/ CHI health Omaha NE Disclosure None 1
More informationUpdate on Early Acute Ischemic Stroke Interventions
Update on Early Acute Ischemic Stroke Interventions Diana Goodman MD Lead Neurohospitalist Maine Medical Center Assistant Professor of Neurology, Tufts University School of Medicine I have no disclosures
More informationEVOLUTION IN SYSTEMS OF STROKE CARE RIDWAN LIN, MD, PHD STROKE & INTERVENTIONAL NEUROLOGY BROWARD HEALTH
EVOLUTION IN SYSTEMS OF STROKE CARE RIDWAN LIN, MD, PHD STROKE & INTERVENTIONAL NEUROLOGY BROWARD HEALTH STROKE SYSTEMS OF CARE: 7. Secondary prevention 1. Primary prevention Patient 3. Emergency transport
More informationDisclosure. Advances in Interventional Neurology. Disclosure. Natural History of Disease 3/15/2018. Vishal B. Jani MD
Advances in Interventional Neurology Disclosure Vishal B. Jani MD Medical Director Vascular Neurology Consultant Interventional Neurology CHI Health Assistant Professor, Creighton University School of
More informationStrokecenter Key lessons of MR CLEAN study
Strokecenter Key lessons of MR CLEAN study Diederik Dippel Disclosures Funded by the Dutch Heart Foundation Nominal, unrestricted grants from AngioCare BV Medtronic/Covidien/EV3 MEDAC Gmbh/LAMEPRO Penumbra
More informationEndovascular Treatment of Ischemic Stroke
Endovascular Treatment of Ischemic Stroke William Thorell, MD Associate Professor Neurosurgery UNMC Co-Director Stroke and Neurovascular Center Nebraska Medicine Overview Definitions of terms Review basic
More informationEndovascular Treatment for Acute Ischemic Stroke: Curtis A. Given II, MD Co-Director, Neurointerventional Services Baptist Physician Lexington
Endovascular Treatment for Acute Ischemic Stroke: Curtis A. Given II, MD Co-Director, Neurointerventional Services Baptist Physician Lexington Disclosures: SWIFT PRIME site (Medtronic) Physician Proctor
More informationInterventional Stroke Treatment
Interventional Stroke Treatment Vishal B. Jani MD Medical Director Vascular Neurology Consultant Interventional Neurology CHI Health Assistant Professor, Creighton University School of Medicine Omaha,
More informationAdvances in Neuro-Endovascular Care for Acute Stroke
Advances in Neuro-Endovascular Care for Acute Stroke Ciarán J. Powers, MD, PhD, FAANS Associate Professor Program Director Department of Neurological Surgery Surgical Director Comprehensive Stroke Center
More informationThe DAWN of a New Era for Wake-up Stroke
The DAWN of a New Era for Wake-up Stroke Alan H. Yee, D.O. Stroke and Critical Care Neurology Department of Neurology University of California Davis Medical Center Objectives Review Epidemiology and Natural
More informationEndovascular Treatment Updates in Stroke Care
Endovascular Treatment Updates in Stroke Care Autumn Graham, MD April 6-10, 2017 Phoenix, AZ Endovascular Treatment Updates in Stroke Care Autumn Graham, MD Associate Professor of Clinical Emergency Medicine
More informationRole of recombinant tissue plasminogen activator in the updated stroke approach
Role of recombinant tissue plasminogen activator in the updated stroke approach Joshua Z. Willey, MD, MS Assistant Professor of Neurology Division of Stroke, Columbia University October 2015 jzw2@columbia.edu
More informationUpdates on Endovascular Therapy
Updates on Endovascular Therapy 5 th Annual Intermountain Stroke Conference October 16, 2017 M. Shazam Hussain, MD, FRCP(C), FAHA Director, Cerebrovascular Center Associate Professor, CCLCM Staff, Vascular
More informationRBWH ICU Journal Club February 2018 Adam Simpson
RBWH ICU Journal Club February 2018 Adam Simpson 3 THROMBOLYSIS Reperfusion therapy has become the mainstay of therapy for ischaemic stroke. Thrombolysis is now well accepted within 4.5 hours. - Improved
More information5/31/2018. Interventional Therapies that Expand Time Windows for Acute Ischemic Stroke Treatment. Disclosures. Impact of clot burden
Good Outcome (%) Rankin 0-2 at 90 days 5/31/2018 Interventional Therapies that Expand Time Windows for Acute Ischemic Stroke Treatment Disclosures Cerenovus: I am on Executive Committee for ARISE2 Trial
More informationAcute Stroke Treatment: Current Trends 2010
Acute Stroke Treatment: Current Trends 2010 Helmi L. Lutsep, MD Oregon Stroke Center Oregon Health & Science University Overview Ischemic Stroke Neuroprotectant trials to watch for IV tpa longer treatment
More informationNeuro-vascular Intervention in Stroke. Will Adams Consultant Neuroradiologist Plymouth Hospitals NHS Trust
Neuro-vascular Intervention in Stroke Will Adams Consultant Neuroradiologist Plymouth Hospitals NHS Trust Stroke before the mid 1990s Swelling Stroke extension Haemorrhagic transformation Intravenous thrombolysis
More informationMechanical thrombectomy beyond the 6 hours. Mahmoud Rayes, MD Medical Director, Stroke program Greenville Memorial Hospital
Mechanical thrombectomy beyond the 6 hours Mahmoud Rayes, MD Medical Director, Stroke program Greenville Memorial Hospital Disclosures None Worldwide statistics 1 IN 6 people will have a stroke at some
More informationMechanical Thrombectomy of Large Vessel Occlusions Using Stent Retriever Devices
Mechanical Thrombectomy of Large Vessel Occlusions Using Stent Retriever Devices Joey English MD, PhD Medical Director, Neurointerventional Services California Pacific Medical Center Hospitals, San Francisco,
More informationStroke Treatment Beyond Traditional Time Windows. Rishi Gupta, MD, MBA
Stroke Treatment Beyond Traditional Time Windows Rishi Gupta, MD, MBA Director, Stroke and Neurocritical Care Endovascular Neurosurgery Wellstar Health System THE PAST THE PRESENT 2015 American Heart Association/American
More informationFigures for Draft Response to IMS III, MR RESCUE, and SYNTHSESIS Trials
Figures for Draft Response to IMS III, MR RESCUE, and SYNTHSESIS Trials Figure 1: Lay Press Judgment May Belie a Deeper Examination of the Data. Truman ultimately defeated Dewey for the Presidency Subject
More informationUpdate on Thrombolysis and Thrombectomy. Seniorprofessur Neurologie UniversitätsKlinikum und Universität Heidelberg
Update on Thrombolysis and Thrombectomy Relevant Disclosures I received financial compensation from Boehringer - Ingelheim for my time and efforts as Chairman of the SC of ECASS 1-3 and from Paion for
More informationMechanical Endovascular Reperfusion Therapy
Get With the Guidelines Stroke Mechanical Endovascular Reperfusion Therapy February 1, 2017 Speaker Lee H. Schwamm, MD Executive Vice Chairman and Director of Stroke/TeleStroke Services, Department of
More informationImaging Stroke: Is There a Stroke Equivalent of the ECG? Albert J. Yoo, MD Director of Acute Stroke Intervention Massachusetts General Hospital
Imaging Stroke: Is There a Stroke Equivalent of the ECG? Albert J. Yoo, MD Director of Acute Stroke Intervention Massachusetts General Hospital Disclosures Penumbra, Inc. research grant (significant) for
More informationBGS Spring Conference 2015
Neuroradiology in hyperacute stroke: what is the UK position? Dr Shelley Renowden Bristol NICE HIS July, 2013 The current evidence on mechanical clot retrieval for treating acute ischaemic stroke shows
More information12/4/2017. Disclosures. Study organization. Stryker Medtronic Penumbra Viz Route 92. Data safety monitoring board Tudor G.
12/4/2017 Update on Stroke Trials:Extending the Window DWI or CTP Assessment with Clinical Mismatch in the Triage of Wake-Up and Late Presenting Strokes Undergoing Neurointervention with Trevo NP001713
More informationInterventional Treatment of Stroke
Interventional Treatment of Stroke Andrew F. Ducruet, MD Barrow Neurological Institute 2018 BNI Stroke Rehab Symposium October 13, 2018 Disclosures Consultant: Medtronic, Penumbra, Cerenovus Lecture Overview
More informationEvidence for Mechanical ThrombectomyFor Acute Ischemic Stroke. Kenneth V Snyder MD PhD SUNY Buffalo, NY
Evidence for Mechanical ThrombectomyFor Acute Ischemic Stroke Kenneth V Snyder MD PhD SUNY Buffalo, NY Disclosure Speaker name:... I have the following potential conflicts of interest to report: Honorarium
More informationParameter Optimized Treatment for Acute Ischemic Stroke
Heart & Stroke Barnett Memorial Lectureship and Visiting Professorship Parameter Optimized Treatment for Acute Ischemic Stroke December 2, 2016, Thunder Bay, Ontario Adnan I. Qureshi MD Professor of Neurology,
More informationPARADIGM SHIFT FOR THROMBOLYSIS IN PATIENTS WITH ACUTE ISCHAEMIC STROKE, FROM EXTENSION OF THE TIME WINDOW TO RAPID RECANALISATION AFTER SYMPTOM ONSET
PARADIGM SHIFT FOR THROMBOLYSIS IN PATIENTS WITH ACUTE ISCHAEMIC STROKE, FROM EXTENSION OF THE TIME WINDOW TO RAPID RECANALISATION AFTER SYMPTOM ONSET Hye Seon Jeong, *Jei Kim Department of Neurology and
More information1/19/2018. Endovascular Therapy for Stroke
Endovascular Therapy for Stroke 1 PROACT II (1999, IA urokinase)first to demonstrate benefit of EST Newer trials (including MERCI in 2005) demonstrated vessel recanalization but no clinical benefit 2 Based
More informationWHY TIMELINESS MATTERS. W&M Wren Association Lecture Series
WHY TIMELINESS MATTERS April 10, 2018 W&M Wren Association Lecture Series Pankajavalli Ramakrishnan, M.D., Ph.D. Stroke Neurologist and Neurointerventionalist Riverside Regional Medical Center Comprehensive
More informationComparison of Five Major Recent Endovascular Treatment Trials
Comparison of Five Major Recent Endovascular Treatment Trials Sample size 500 # sites 70 (100 planned) 316 (500 planned) 196 (833 estimated) 206 (690 planned) 16 10 22 39 4 Treatment contrasts Baseline
More informationJointly provided by Potomac Center for Medical Education and Rockpointe Supported by an educational grant from Genentech, A Member of the Roche Group
Jointly provided by Potomac Center for Medical Education and Rockpointe Supported by an educational grant from Genentech, A Member of the Roche Group Faculty Speakers Deepak L. Bhatt, MD, MPH, FACC, FAHA,
More informationESCAPE Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times
ESCAPE Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times Michael D Hill, Mayank Goyal on behalf of the ESCAPE Trial
More informationBY MARILYN M. RYMER, MD
Lytics, Devices, and Advanced Imaging The evolving art and science of acute stroke intervention. BY MARILYN M. RYMER, MD In 1996, when the US Food and Drug Administration (FDA) approved the use of intravenous
More informationACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke
ACUTE ISCHEMIC STROKE Current Treatment Approaches for Acute Ischemic Stroke EARLY MANAGEMENT OF ACUTE ISCHEMIC STROKE Rapid identification of a stroke Immediate EMS transport to nearest stroke center
More informationOptimizing Care for Patients with Acute Ischemic Stroke Thrombolytic Therapy for Low NIHSS
Optimizing Care for Patients with Acute Ischemic Stroke Thrombolytic Therapy for Low NIHSS Nerses Sanossian, MD, FAHA Presentation not eligible for CME credit Disclosures Today s objectives Case study:
More informationBetter identification of patients who may benefit from therapy
Jon Jui MD, MPH Large Vessel Occlusion Low rates of re-canalization after tpa Only 25 % of large vessel strokes re-canalization after tpa Newer invasive techniques Solitaire vs Merci Better identification
More informationEndovascular Clot Retrieval. Teddy Wu Neurologist (and Stroke enthusiast) Christchurch Hospital
Endovascular Clot Retrieval Teddy Wu Neurologist (and Stroke enthusiast) Christchurch Hospital Something you can do tomorrow Melbourne half marathon 2016 In 2009 Simple approach to stroke - blocked artery,
More informationAcute Stroke Management What is State of the Art?
Acute Stroke Management What is State of the Art? Karl-Titus Hoffmann Department of Neuroradiologie University of Leipzig / University Hospital Leipzig Disclosure Speaker name: Karl-Titus Hoffmann I have
More informationLatest Advances in the Neurointerventional Treatment of Ischemic Stroke P A C I F I C N E U R O. O R G
Latest Advances in the Neurointerventional Treatment of Ischemic Stroke Neurointerventional Management of Ischemic Stroke 1. Thrombectomy for acute ischemic stroke 2. Carotid artery stenting 3. Management
More informationEpidemiology. Epidemiology 6/1/2015. Cerebral Ischemia
Presenter Disclosure Information Paul Nyquist MD/MPH FCCM FAHA Updates on the Acute Care of Ischemic Stroke and Intracranial Hemorrhage Updates on the Acute Care of Ischemic Stroke Paul Nyquist MD/MPH,
More informationStroke: The First Critical Hour. Alina Candal, RN, PCC, MICN Kevin Andruss, MD, FACEP
Stroke: The First Critical Hour Alina Candal, RN, PCC, MICN Kevin Andruss, MD, FACEP Disclosures We have no actual or potential conflicts of interest in relation to this presentation. Objectives Discuss
More informationCVA Updates Karen Greenberg, DO, FACOEP. Director Neurologic Emergency Department Crozer Chester Medical Center
CVA Updates 2018 Karen Greenberg, DO, FACOEP Director Neurologic Emergency Department Crozer Chester Medical Center Disclosure I have the following financial relationship with the manufacturer of any commercial
More informationACUTE ISCHEMIC STROKE
ENDOVASCULAR MECHANICAL THROMBECTOMY IN PATIENTS WITH ACUTE ISCHEMIC STROKE HHS Stroke Annual Review March 7 and March 8, 2018 Objectives To review the stroke endovascular mechanical thrombectomy evidence
More informationCase 1 5/26/2017 ENDOVASCULAR MECHANICAL THROMBECTOMY IN PATIENTS WITH ACUTE ISCHEMIC STROKE
ENDOVASCULAR MECHANICAL THROMBECTOMY IN PATIENTS WITH ACUTE ISCHEMIC STROKE Rhonda Whiteman Racing Against the Clock Workshop June 1, 2017 Objectives To discuss the hyperacute ischemic stroke management
More informationEvolution of Mission: Lifeline Stroke The Stroke of the Severity-Based Stroke Triage Algorithm
Evolution of Mission: Lifeline Stroke The Stroke of the Severity-Based Stroke Triage Algorithm Peter D. Panagos, MD, FAHA, FACEP Professor of Emergency Medicine and Neurology Washington University Saint
More informationAcute Ischemic Stroke Imaging. Ronald L. Wolf, MD, PhD Associate Professor of Radiology
Acute Ischemic Stroke Imaging Ronald L. Wolf, MD, PhD Associate Professor of Radiology Title of First Slide of Substance An Illustrative Case 2 Disclosures No financial disclosures Off-label uses of some
More informationframework for flow Objectives Acute Stroke Treatment Collaterals in Acute Ischemic Stroke framework & basis for flow
Acute Stroke Treatment Collaterals in Acute Ischemic Stroke Objectives role of collaterals in acute ischemic stroke collateral therapeutic strategies David S Liebeskind, MD Professor of Neurology & Director
More informationEndovascular Neurointervention in Cerebral Ischemia
Endovascular Neurointervention in Cerebral Ischemia Beyond Thrombolytics Curtis A. Given II, MD Co-Director, Neurointerventional Services Baptist Physician Lexington 72 y/o female with a recent diagnosis
More informationAHA/ASA Guideline. Downloaded from by on November 7, 2018
AHA/ASA Guideline 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular
More informationDISCLOSURES. Learning Objectives. David Lee Gordon, MD, FAHA Update in Stroke 2007 FINANCIAL DISCLOSURE UNLABELED/UNAPPROVED USES DISCLOSURE
Acute Stroke Care and the Role of EMS Ryan Hakimi, DO, MS April 30, 2015 Assistant Professor Director, Critical Care Neurology Department of Neurology University of Oklahoma Health Sciences Center DISCLOSURES
More informationCode Stroke Intervention: Endovascular Therapies for Stroke J. DIEGO LOZANO MD INTERVENTIONAL NEURORADIOLOGY
Code Stroke Intervention: Endovascular Therapies for Stroke J. DIEGO LOZANO MD INTERVENTIONAL NEURORADIOLOGY Disclosures None Part A. Objectives Epidemiology of AIS and of ELVO Concept: Acute Ischemic
More informationHistorical. Medical Policy
Medical Policy Subject: Mechanical Embolectomy for Treatment of Acute Stroke Policy #: SURG.00098 Current Effective Date: 01/01/2016 Status: Revised Last Review Date: 08/06/2015 Description/Scope This
More informationAcute Stroke Care: the Nuts and Bolts of it. ECASS I and II ATLANTIS. Chris V. Fanale, MD Colorado Neurological Institute Swedish Medical Center
Acute Stroke Care: the Nuts and Bolts of it Chris V. Fanale, MD Colorado Neurological Institute Swedish Medical Center ECASS I and II tpa for patients presenting
More informationStroke Cart Improves Efficiency in Acute Ischemic Stroke Intervention
Stroke Cart Improves Efficiency in Acute Ischemic Stroke Intervention MR Amans, F Settecase, R Darflinger, M Alexander, A Nicholson, DL Cooke, SW Hetts, CF Dowd, RT Higashida, VV Halbach Interventional
More informationOngoing Acute Stroke Studies 10/5/2015
Ongoing Acute Stroke Studies 10/5/2015 Wade S. Smith, MD, PhD Director UCSF Neurovascular Service Daryl R. Gress Professor of Neurocritical Care and Stroke Disclosures NIH U10 NS 086494 (PI) NorCal RCC
More informationPractical Considerations in the Early Treatment of Acute Stroke
Practical Considerations in the Early Treatment of Acute Stroke Matthew E. Fink, MD Neurologist-in-Chief Weill Cornell Medical College New York-Presbyterian Hospital mfink@med.cornell.edu Disclosures Consultant
More informationAlex Abou-Chebl, MD Associate Professor of Neurology and Neurosurgery Director of Neurointerventional Services Director of Vascular and
Alex Abou-Chebl, MD Associate Professor of Neurology and Neurosurgery Director of Neurointerventional Services Director of Vascular and Interventional Neurology Fellowships University of Louisville School
More informationEndovascular stroke research after MRCLEAN. W. van Zwam
1 Endovascular stroke research after MRCLEAN W. van Zwam 2 Layout 1. What do we know by now 2. Next research questions Anesthesia Aspiration 3. Ongoing and future research Dutch initiatives 3 4 N=70 Intervention
More informationInterventional Neuroradiology. & Stroke INR PROCEDURES INR PROCEDURES. Dr Steve Chryssidis. 25-Sep-17. Interventional Neuroradiology
Interventional Neuroradiology Interventional Neuroradiology & Stroke Dr Steve Chryssidis Interventional Neuroradiology (INR) is a subspecialty within Radiology INR -- broadly defined as treatment by endovascular
More informationLessons Learned from IMS III: Implications for the Future
Lessons Learned from IMS III: Implications for the Future Pooja Khatri, MD, MSc Professor, Dept of Neurology Director of Acute Stroke, UC Stroke Team University of Cincinnati Disclosures Univ of Cincinnati
More informationAcute Stroke Management Conference 2019: Stroke Clinical Vignettes
Acute Stroke Management Conference 2019: Stroke Clinical Vignettes Cynthia Kenmuir MD PhD Director of Stroke Program, UPMC Altoona Director of Neurointerventional Program, UPMC Altoona 2015 Guideline for
More informationIMAGING IN ACUTE ISCHEMIC STROKE
IMAGING IN ACUTE ISCHEMIC STROKE Timo Krings MD, PhD, FRCP (C) Professor of Radiology & Surgery Braley Chair of Neuroradiology, Chief and Program Director of Diagnostic and Interventional Neuroradiology;
More informationManaging the Measures: A Serious Look at Key Abstraction Concepts for the Comprehensive Stroke (CSTK) Measure Set Session 2
Managing the Measures: A Serious Look at Key Abstraction Concepts for the Comprehensive Stroke (CSTK) Measure Set Session 2 January 28, 2015 1 to 3 PM Central Time Continuing Education Credit This course
More informationIMAGING IN ACUTE ISCHEMIC STROKE
IMAGING IN ACUTE ISCHEMIC STROKE Timo Krings MD, PhD, FRCP (C) Professor of Radiology & Surgery Braley Chair of Neuroradiology, Chief and Program Director of Diagnostic and Interventional Neuroradiology;
More informationIs there even a time window?
Is there even a time window? A brief summary of key 2018 trials: DAWN and DEFUSE-3 For Neurosciences Update Conference, February 22, 2018 Maxim D. Hammer, M.D. Executive Summary Based on DAWN and DEFUSE-3,
More informationStroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%
Stroke Update Michel Torbey, MD, MPH, FAHA, FNCS Medical Director, Neurovascular Stroke Center Professor Department of Neurology and Neurosurgery The Ohio State University Wexner Medical Center Objectives
More informationAcute Stroke Identification and Treatment
Acute Stroke Identification and Treatment James S. McKinney, MD, FAHA Medical Director, NHRMC Stroke Center SE NC is located in the buckle of the Stroke Belt, seeing the highest stroke incidence and mortality
More informationPatient selection for i.v. thrombolysis and thrombectomy
3 rd Congress of the European Academy of Neurology Amsterdam, The Netherlands, June 24 27, 2017 Teaching Course 8 Acute treatment and early secondary prevention of stroke Level 2 Patient selection for
More informationPr Roman Sztajzel Service de Neurologie HUG
Pr Roman Sztajzel Service de Neurologie HUG Conflict of interest: none IV THROMBOLYSIS AND ENDOVASCULAR THROMBECTOMY approved treatments of acute stroke main criteria time (delay) IV thrombolysis radiological
More informationFrom interventional cardiology to cardio-neurology. A new subspeciality
From interventional cardiology to cardio-neurology. A new subspeciality in the future? Prof. Andrejs Erglis, MD, PhD Pauls Stradins Clinical University Hospital University of Latvia Riga, LATVIA Disclosure
More informationCT Perfusion is Essential for Stroke Triage. Maarten Lansberg, MD PhD Associate Professor of Neurology Stanford University, Stanford Stroke Center
CT Perfusion is Essential for Stroke Triage Maarten Lansberg, MD PhD Associate Professor of Neurology Stanford University, Stanford Stroke Center CT Perfusion is Essential for Stroke Triage Disclosures:
More informationPerils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion
Perils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion Aman B. Patel, MD Robert & Jean Ojemann Associate Professor Director, Cerebrovascular Surgery Director, Neuroendovascular
More informationIntravenous thrombolysis State of Art. Carlos A. Molina Stroke Unit. Hospital Vall d Hebron Barcelona
Intravenous thrombolysis State of Art Carlos A. Molina Stroke Unit. Hospital Vall d Hebron Barcelona Independent predictors of good outcome after iv tpa Factor SE OR(95%CI) p Constant 0.467(0.69) Recanalization
More informationAcute Management of Stroke due to Intracranial Steno-occlusion. Joon-Tae Kim, MD, PhD Department of Neurology Chonnam National University Hospital
Acute Management of Stroke due to Intracranial Steno-occlusion Joon-Tae Kim, MD, PhD Department of Neurology Chonnam National University Hospital None Disclosure Contents Current status of acute management
More informationWhat Do You Think of My Posterior?
What Do You Think of My Posterior? Posterior Stroke and Stroke Mimics Peter Panagos, MD, FACEP, FAHA Associate Professor Emergency Medicine and Neurology Washington University School of Medicine Disclosures
More informationSupplementary Online Content
Supplementary Online Content Badhiwala JH, Nassiri F, Alhazzani W, et al. Endovascular Thrombectomy for Acute Ischemic Stroke: A Meta-analysis. JAMA. doi:10.1001/jama.2015.13767. etable 1. The modified
More informationIntra-arterial Stroke Therapy: 2018 Update
Intra-arterial Stroke Therapy: 2018 Update Expanding the Treatment Window Parita Bhuva, M.D. Medical Director Enrolling investigator Stryker Neurovascular (DAWN trial) Disclosures Most common large vessel
More informationStroke Systems of Care
Comprehensive Stroke and Cerebrovascular Center Stroke Systems of Care Dana Stradling RN MSN CNRN UC Irvine Stroke Manager dstradli@uci.edu Why Stroke Systems? No. 4 th 5 th cause of death in the U.S.
More informationVolume 13 - Issue 3, Interventions
Volume 13 - Issue 3, 2013 - Interventions Interventional Radiology And Stroke Therapy Authors Dr. Leo Lawler Dr. Matt Crockett Dr. Eoin Kavanagh Prof. Sean Murphy Stroke Physician Mater Misericordiae University
More informationMaximising Delivery of Thrombectomy
Maximising Delivery of Thrombectomy Professor Gary Ford Chief Executive Officer, Oxford Academic Health Science Network Consultant Stroke Physician, Oxford University Hospitals Visiting Professor of Clinical
More informationSignificant Relationships
Opening Large Vessels During Acute Ischemic Stroke Significant Relationships Wade S Smith, MD, PhD Director UCSF Neurovascular Service Professor of Neurology Daryl R Gress Endowed Chair of Neurocritical
More informationBackground. Recommendations for Imaging of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association
for Imaging of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association An Scientific Statement from the Stroke Council, American Heart Association and American Stroke Association
More informationEndovascular Treatment for Acute Ischemic Stroke: Considerations from Recent Randomized Trials
Published online: March 13, 2015 1664 9737/15/0034 0115$39.50/0 Review Endovascular Treatment for Acute Ischemic Stroke: Considerations from Recent Randomized Trials Manabu Shirakawa a Shinichi Yoshimura
More informationACUTE STROKE IMAGING
ACUTE STROKE IMAGING Mahesh V. Jayaraman M.D. Director, Inter ventional Neuroradiology Associate Professor Depar tments of Diagnostic Imaging and Neurosurger y Alper t Medical School at Brown University
More informationKPNC Stroke EXPRESS EXpediting the PRocess of Evaluating & Stopping Stroke
KPNC Stroke EXPRESS EXpediting the PRocess of Evaluating & Stopping Stroke Jeffrey G. Klingman, MD 1 Disclosures None 75% DTN < 60 50% DTN < 45 Why should we care about DTN?: Time is brain 2 million nerve
More informationMark J. Alberts, MD, FAHA, FANA Vice-Chair, Dept of Neurology Professor of Neurology UT Southwestern Medical Center Dallas, TX
Interventional Therapies for Cerebrovascular Diease: The Good, The Bad, The Needed, and The Few 1 Mark J. Alberts, MD, FAHA, FANA Vice-Chair, Dept of Neurology Professor of Neurology UT Southwestern Medical
More informationACUTE STROKE INTERVENTION: THE ROLE OF THROMBECTOMY AND IA LYSIS
Associate Professor of Neurology Director of Neurointerventional Services University of Louisville School of Medicine ACUTE STROKE INTERVENTION: THE ROLE OF THROMBECTOMY AND IA LYSIS Conflict of Interest
More information